Table 1.
Demographic, clinical, neuropsychological and neuroimaging characteristics of the participants.
| MS (n = 476) |
HS (n = 110) |
MS vs. HS | |||||
|---|---|---|---|---|---|---|---|
| Female | Male | t/Z | Female | Male | t | ||
| Number (%) | n = 337 (70%) | n = 139 (30%) | n = 54 (50%) | n = 56 (50%) | P < 0.001*** | ||
| Age (years) | 35 ± 10 | 34 ± 9 | P = 0.58* | 38 ± 12 | 30 ± 11 | P = 0.01 * | P = 0.70* |
| Disease duration (months) EDSS (1–10) | 16 ± 11 | 16 ± 10 | P = 0.88* | na | na | na | na |
| Baseline | 1.5 (0–5) | 1.5 (0–5) | P = 0.41** | na | na | na | na |
| Follow-up | 1.5 (0–5) | 1.0 (0–5) | P = 0.54** | ||||
| Composite cognitive performance score (Z-score) | |||||||
| Baseline | −0.34 ± 1.04 | −0.26 ± 0.97 | P = 0.53* | na | na | na | na |
| Follow-up | −0.24 ± 1.07 | −0.25 ± 1.04 | P = 0.92* | ||||
| Composite memory performance (Z-score) | |||||||
| Baseline | −0.08 ± 0.75 | −0.01 ± 0.73 | P = 0.47* | na | na | na | na |
| Follow-up | −0.09 ± 0.88 | −0.002 ± 0.84 | P = 0.38* | ||||
| T2 lesion volume (log10 mL) | |||||||
| Baseline | 0.38 ± 0.6 | 0.42 ± 0.6 | P = 0.58* | na | na | na | na |
| Follow-up | 0.46 ± 0.6 | 0.48 ± 0.6 | P = 0.76* | ||||
| Hippocampal lesion volume (log10 mL) | |||||||
| Baseline | 0.55 ± 0.32 | 0.57 ± 0.26 | P = 0.78* | na | na | na | na |
| Follow-up | 0.55 ± 0.31 | 0.60 ± 0.25 | P = 0.40* | ||||
EDSS, expanded disability status scale; HS, healthy subjects; MS, multiple sclerosis.
Variables are presented as means ± standard deviation (SD) or median (range).
P-values derived from Student’s two-tailed t-test (age, disease duration, composite cognitive performance Z-score (average of PASAT and MUSIC Z-scores), composite memory performance Z-score (average of memory-related subtests of the MUSIC test) and T2 and hippocampal lesion volumes).
P-values derived from Mann–Whitney U-test (EDSS).
P-values derived from Pearson’s chi-squared test (sex). Significant P-values are marked in bold.